Skip to main content

Michael Alosco

NIH Rank #909
  • Top 5% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11165146Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Neurology
  • Radiology

NIH Funding · FY2024

Linked Award Amount
$5.7M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#909
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Michael Alosco. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Michael Alosco as a PI. Multi-PI records show the full award amount for context.

  • 1R01NS139383-01R01
    Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II
    $3.3M
    award amount
  • 4R01NS122854-02R01
    Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms
    $816.8K
    award amount
  • 5R01AG077588-02R01
    Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research
    $811.7K
    award amount
  • 5R01NS119651-04R01
    Risk for Later-Life Cognitive Impairment, Neurobehavioral Dysregulation, and Dementia in Former Soccer and American Football Players: The Head Impact and Trauma Surveillance Study (HITSS)
    $790.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Michael Alosco as a PI.

FY2024 award administered by Boston University (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Boston University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #909
  7. 2024
    Entered Top 25% Nationally
    Ranked #909
  8. 2024
    Entered Top 10% Nationally
    Ranked #909
  9. 2024
    Entered Top 5% Nationally
    Ranked #909
  10. 2025
    $10M Cumulative Funding
  11. 2025
    R01 Grant Holder